Payment Policy:Modifier to Procedure Code Validation: Payment Modifiers Reference Number: CC.PP.028

Size: px
Start display at page:

Download "Payment Policy:Modifier to Procedure Code Validation: Payment Modifiers Reference Number: CC.PP.028"

Transcription

1 Payment Policy:: Payment Modifiers Reference Number: CC.PP.028 Product Types: ALL Effective Date: 01/01/2013 Last Review Date: 02/23/2018 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications Revision Log Policy Overview Providers append modifiers to procedures codes to indicate that a procedure or service has been altered by some circumstance, but the definition of the procedure or the procedure code itself is unchanged. When a provider bills a modifier that is invalid for the procedure code billed, the claim line containing the invalid modifier to procedure code combination will be denied. This policy is relevant to modifiers identified as affecting payment. The Centers for Medicare and Medicaid Services (CMS), the American Medical Association (AMA) and public-domain specialty societies determine payment modifiers that are appropriate for billing with certain procedure codes. The AMA publishes the Current Procedural Terminology (CPT) HCPCS Level I modifiers and CMS publishes the valid list of HCPCS Level II modifiers. According to the AMA (2016): A modifier provides the means to report or indicate that a service or procedure that has been performed has been altered by some specific circumstance but has not changed in its definition or code. Modifiers also enable healthcare professionals to effectively respond to payment policy requirements established by other entities (p. 709). Application This policy applies to Professional and Outpatient institutional claims. Policy Description Reimbursement Claims Reimbursement Edit The health plan s code editing software will evaluate individual claim lines for invalid payment modifier to procedure code combinations. The rule will deny procedure codes when billed with a payment modifier that is inappropriate for the service billed or not clinically likely for the procedure code billed. This rule reviews modifier to procedure code combinations on the current claim only and does not review historical claims. Page 1 of 6

2 Rationale for Edit Providers should bill the correct payment modifier for the appropriate procedures. Coding and Modifier Information This payment policy references Current Procedural Terminology (CPT ). CPT is a registered trademark of the American Medical Association. All CPT codes and descriptions are copyrighted 2017, American Medical Association. All rights reserved. CPT codes and CPT descriptions are from current manuals and those included herein are not intended to be allinclusive and are included for informational purposes only. Codes referenced in this payment policy are for informational purposes only. Inclusion or exclusion of any codes does not guarantee coverage. Providers should reference the most up-to-date sources of professional coding guidance prior to the submission of claims for reimbursement of covered services. Modifier Descriptor 22 Increased Procedural Services 23 Unusual Anesthesia 24 Unrelated Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional During a Postoperative Period 25 Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service 26 Professional Component 27 Multiple Outpatient Hospital E/M Encounters on the Same Date 32 Mandated Services 33 Preventive Service 47 Anesthesia by Surgeon 50 Bilateral Procedure 51 Multiple Procedures 52 Reduced Services 53 Discontinued Procedure 54 Surgical Care Only 55 Postoperative Management Only 56 Preoperative Management Only 57 Decision for Surgery 58 Staged or Related Procedure or Service by the Same Physician During the Postoperative Period 59 Distinct Procedural Service 62 Two Surgeons 63 Procedure Performed on Infants less than 4 kg 66 Surgical Team Page 2 of 6

3 73 Discontinued Outpatient Hospital/Ambulatory Surgery Center (ASC) Procedure Prior to the Administration of Anesthesia 74 Discontinued Outpatient Hospital/Ambulatory Surgery Center (ASC) Procedure After Administration of Anesthesia 76 Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional 77 Repeat Procedure or Service by Another Physician or Other Qualified Health Care Professional 78 Unplanned Return to the Operating/Procedure Room by the Same Physician Following Initial Procedure for a Related Procedure During the Postoperative Period 79 Unrelated Procedure or Service by the Same Physician During the Postoperative Period 80 Assistant Surgeon 81 Minimum Assistant Surgeon 82 Assistant Surgeon (when qualified resident surgeon not available): The unavailability of a qualified resident surgeon is a prerequisite for use of modifier 82 appended to the usual procedure code number(s). 90 Reference (Outside) Laboratory 91 Repeat Clinical Diagnostic Laboratory Test 92 Alternative Laboratory Platform Testing 95 Synchronous Telemedicine Service Rendered Via a Real-Time Interactive Audio and Video Telecommunications System 96 Habilitative Services 97 Rehabilitative Services 99 Multiple Modifiers AA Anesthesia Services Performed Personally by Anesthesiologist AD Medical Supervision by a Physician: More than 4 Concurrent Anesthesia Procedures AR Physician Provider Services in a Physician Scarcity Area AS Physician Assistant, Nurse Practitioner, or Clinical Nurse Specialist Services for Assistant at Surgery QK Medical direction of two, Three, or four concurrent anesthesia procedures involving qualified individuals. QS Monitored anesthesia care service QW CLIA Waived Test QX CRNA Service : With Medical Direction by a Physician QY Medical direction of one certified registered nurse anesthetist (CRNA) by an anesthesiologist. QZ CRNA Service: Without medical direction by a physician TC Technical Component XE Separate encounter, a service that is distinct because it occurred during a separate encounter XP Separate practitioner, a service that is distinct because it was performed by a different practitioner Page 3 of 6

4 XS XU Separate structure, a service that is distinct because it was performed on a separate organ/structure Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service Definitions 1. HealthCare Common Procedure Coding System (HCPCS), Level I Modifiers: Also known as CPT modifiers consisting of two numeric digits. These modifiers are in the range of The list is updated annually by the AMA. 2. HealthCare Common Procedure Coding System (HCPCS), Level II Modifiers: Also known as the HCPCS modifiers and consist of two alpha-numeric characters. These modifiers are in the range of AA-VP. The list is updated annually by the CMS. 3. Modifier: Two digit numeric or alpha-number descriptor that is used by providers to indicate that a service or procedure has been altered by a specific circumstance, but the procedure code and definition is unchanged. 4. Modifiers Affecting Payment: Modifiers which impact how a claim or claim line will be reimbursed. Related Policies [Insert text or Not Applicable ] Related Documents or Resources [Insert text, hyperlinks, or Not Applicable ] References 1. Current Procedural Terminology (CPT ), HCPCS.html 3. HCPCS Level II, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), ICD-10-CM Official Draft Code Set, Centers for Medicare and Medicaid Services, CMS Manual System and other CMS publications and services. Revision History 09/09/2016 Corrected Modifier definitions for QW and QX 02/24/2018 Converted to updated template, conducted review, removed Modifier -21; Added Modifiers: -23,-32,-47,-63,-77,-90,-92,-95,-96,-97,-99,-QS,-XO,- XP,-XS,-XU Important Reminder Page 4 of 6

5 For the purposes of this payment policy, Health Plan means a health plan that has adopted this payment policy and that is operated or administered, in whole or in part, by Centene Management Company, LLC, or any other of such health plan s affiliates, as applicable. The purpose of this payment policy is to provide a guide to payment, which is a component of the guidelines used to assist in making coverage and payment determinations and administering benefits. It does not constitute a contract or guarantee regarding payment or results. Coverage and payment determinations and the administration of benefits are subject to all terms, conditions, exclusions and limitations of the coverage documents (e.g., evidence of coverage, certificate of coverage, policy, contract of insurance, etc.), as well as to state and federal requirements and applicable plan-level administrative policies and procedures. This payment policy is effective as of the date determined by Health Plan. The date of posting may not be the effective date of this payment policy. This payment policy may be subject to applicable legal and regulatory requirements relating to provider notification. If there is a discrepancy between the effective date of this payment policy and any applicable legal or regulatory requirement, the requirements of law and regulation shall govern. Health Plan retains the right to change, amend or withdraw this payment policy, and additional payment policies may be developed and adopted as needed, at any time. This payment policy does not constitute medical advice, medical treatment or medical care. It is not intended to dictate to providers how to practice medicine. Providers are expected to exercise professional medical judgment in providing the most appropriate care, and are solely responsible for the medical advice and treatment of members. This payment policy is not intended to recommend treatment for members. Members should consult with their treating physician in connection with diagnosis and treatment decisions. Providers referred to in this policy are independent contractors who exercise independent judgment and over whom Health Plan has no control or right of control. Providers are not agents or employees of Health Plan. This payment policy is the property of Centene Corporation. Unauthorized copying, use, and distribution of this payment policy or any information contained herein are strictly prohibited. Providers, members and their representatives are bound to the terms and conditions expressed herein through the terms of their contracts. Where no such contract exists, providers, members and their representatives agree to be bound by such terms and conditions by providing services to members and/or submitting claims for payment for such services. Note: For Medicaid members, when state Medicaid coverage provisions conflict with the coverage provisions in this payment policy, state Medicaid coverage provisions take precedence. Please refer to the state Medicaid manual for any coverage provisions pertaining to this payment policy. Note: For Medicare members, to ensure consistency with the Medicare National Coverage Determinations (NCD) and Local Coverage Determinations (LCD), all applicable NCDs and Page 5 of 6

6 LCDs should be reviewed prior to applying the criteria set forth in this payment policy. Refer to the CMS website at for additional information Centene Corporation. All rights reserved. All materials are exclusively owned by Centene Corporation and are protected by United States copyright law and international copyright law. No part of this publication may be reproduced, copied, modified, distributed, displayed, stored in a retrieval system, transmitted in any form or by any means, or otherwise published without the prior written permission of Centene Corporation. You may not alter or remove any trademark, copyright or other notice contained herein. Centene and Centene Corporation are registered trademarks exclusively owned by Centene Corporation. Page 6 of 6

Payment Policy: Clinical Validation of Modifer 25 Reference Number: CC.PP.013 Product Types: ALL

Payment Policy: Clinical Validation of Modifer 25 Reference Number: CC.PP.013 Product Types: ALL Payment Policy: Clinical Validation of Modifer 25 Reference Number: CC.PP.013 Product Types: ALL Effective Date: 01/01/2013 Last Review Date: 02/24/2018 Coding Implications Revision Log See Important Reminder

More information

Payment Policy: New Patient Reference Number: CC.PP.036 Product Types: ALL

Payment Policy: New Patient Reference Number: CC.PP.036 Product Types: ALL Payment Policy: New Patient Reference Number: CC.PP.036 Product Types: ALL Effective Date: 01/01/2014 Last Review Date: 03/10/2018 Coding Implications Revision Log See Important Reminder at the end of

More information

Payment Policy: Unbundled Professional Services Reference Number: CC.PP.043 Product Types: ALL

Payment Policy: Unbundled Professional Services Reference Number: CC.PP.043 Product Types: ALL Payment Policy: Reference Number: CC.PP.043 Product Types: ALL Effective Date: 01/01/2014 Last Review Date: 03/01/2018 Coding Implications Revision Log See Important Reminder at the end of this policy

More information

Payment Policy: Code Editing Overview Reference Number: CC.PP.011 Product Types: ALL Effective Date: 01/01/2013 Last Review Date: 06/28/2018

Payment Policy: Code Editing Overview Reference Number: CC.PP.011 Product Types: ALL Effective Date: 01/01/2013 Last Review Date: 06/28/2018 Payment Policy: Code Editing Overview Reference Number: CC.PP.011 Product Types: ALL Effective Date: 01/01/2013 Last Review Date: 06/28/2018 Coding Implications Revision Log See Important Reminder at the

More information

Payment Policy: Unbundled Surgical Procedures Reference Number: CC.PP.045 Product Types: ALL

Payment Policy: Unbundled Surgical Procedures Reference Number: CC.PP.045 Product Types: ALL Payment Policy: Unbundled Surgical Procedures Reference Number: CC.PP.045 Product Types: ALL Effective Date: 01/01/2014 Last Review Date: 03/01/2018 Coding Implications Revision Log See Important Reminder

More information

Payment Policy: Leveling of Emergency Room Services Reference Number: TX.PP.053 Product Types: ALL

Payment Policy: Leveling of Emergency Room Services Reference Number: TX.PP.053 Product Types: ALL Payment Policy: Leveling of Emergency Room Services Reference Number: TX.PP.053 Product Types: ALL Effective Date: 10/01/2017 Last Review Date: See Important Reminder at the end of this policy for important

More information

Rebundling and NCCI Editing

Rebundling and NCCI Editing Policy Number CCR10082014RP Rebundling and NCCI Editing Approved By UnitedHealthcare Medicare Committee Current Approval Date 10/08/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable

More information

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy Subject: Modifier Rules CT Policy: 0017 Effective: 11/18/2017 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products and policy criteria listed below.

More information

Corporate Reimbursement Policy

Corporate Reimbursement Policy Corporate Reimbursement Policy File Name: Origination: Last Review: Next Review: modifier_guidelines 1/2000 11/2017 11/2018 Description Policy A modifier enables a provider to report that a service or

More information

Rebundling Policy Annual Approval Date

Rebundling Policy Annual Approval Date Policy Number 2017R0056A Rebundling Policy Annual Approval Date 11/9/2016 Approved By REIMBURSEMENT POLICY CMS-1500 Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY

More information

Payment Policy: Status B Bundled Services Reference Number: CC.PP.046 Product Types: ALL

Payment Policy: Status B Bundled Services Reference Number: CC.PP.046 Product Types: ALL Payment Policy: Reference Number: CC.PP.046 Product Types: ALL Effective Date: 01/01/2014 Last Review Date: 03/10/2018 Coding Implications Revision Log See Important Reminder at the end of this policy

More information

One or More Sessions Policy

One or More Sessions Policy One or More Sessions Policy Policy Number 2017R0118B Annual Approval Date 7/12/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY You are responsible

More information

Multiple Procedure Payment Reduction (MPPR) for Surgical Procedures

Multiple Procedure Payment Reduction (MPPR) for Surgical Procedures Policy Number MPS04242013RP Approved By UnitedHealthcare Medicare Committee Current Approval Date 03/26/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare

More information

Moda Health Reimbursement Policy Overview

Moda Health Reimbursement Policy Overview Manual: Policy Title: Reimbursement Policy Moda Health Reimbursement Policy Overview Section: Administrative Subsection: None Date of Origin: 7/6/2011 Policy Number: RPM001 Last Updated: 1/9/2017 Last

More information

Reference Guide to Understanding Modifiers

Reference Guide to Understanding Modifiers Reference Guide to Understanding Modifiers The modifiers outlined in this reference guide are most often used in eye care, and is not a complete listing of available modifiers to date. The definitions

More information

Modifier 51 - Multiple Procedure Fee Reductions

Modifier 51 - Multiple Procedure Fee Reductions Manual: Policy Title: Reimbursement Policy Modifier 51 - Multiple Procedure Fee Reductions Section: Modifiers Subsection: None Date of Origin: Last Updated: 1/1/2000 Policy Number: 4/10/2018 Last Reviewed:

More information

Professional/Technical Component Policy, Professional

Professional/Technical Component Policy, Professional Professional/Technical Component Policy, Professional REIMBURSEMENT POLICY Policy Number 2018R0012F Annual Approval Date 7/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT

More information

Reopening and Redetermination Submissions

Reopening and Redetermination Submissions A CMS Medicare Administrative Contractor http://www.ngsmedicare.com Reopening and Redetermination Submissions Understanding your next steps are very important for quick reimbursement and providers are

More information

Profilnine is indicated for: Prevention and control of bleeding in patients with factor IX deficiency (hemophilia B).

Profilnine is indicated for: Prevention and control of bleeding in patients with factor IX deficiency (hemophilia B). Clinical Policy: (Bebulin, Profilnine) Reference Number: CP.PHAR.219 Effective Date: 05.01.16 Last Review Date: 02.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder

More information

Professional/Technical Component Policy

Professional/Technical Component Policy Professional/Technical Component Policy Policy Number 2018R0012A Annual Approval Date 7/12/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY You are

More information

Professional/Technical Component Policy Annual Approval Date

Professional/Technical Component Policy Annual Approval Date Policy Number 2018R0012B Professional/Technical Component Policy Annual Approval Date 7/13/2017 Approved By REIMBURSEMENT POLICY CMS-1500 Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Bebulin, Profilnine) Reference Number: CP.PHAR.219 Effective Date: 05.01.16 Last Review Date: 02.19 Line of Business: Medicaid, HIM-Medical Benefit Coding Implications Revision Log See

More information

Clinical Policy: Belatacept (Nulojix) Reference Number: CP.PHAR.201 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Belatacept (Nulojix) Reference Number: CP.PHAR.201 Effective Date: Last Review Date: Line of Business: Medicaid Clinical Policy: (Nulojix) Reference Number: CP.PHAR.201 Effective Date: 03.01.16 Last Review Date: 11.17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of

More information

MAXIMUM FREQUENCY PER DAY POLICY

MAXIMUM FREQUENCY PER DAY POLICY MAXIMUM FREQUENCY PER DAY POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE169.54 T0 Effective Date: November 20, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE

More information

Clinical Policy: Eltrombopag (Promacta) Reference Number: CP.PHAR.180

Clinical Policy: Eltrombopag (Promacta) Reference Number: CP.PHAR.180 Clinical Policy: (Promacta) Reference Number: CP.PHAR.180 Effective Date: 03/16 Last Review Date: 03/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

MAXIMUM FREQUENCY PER DAY POLICY

MAXIMUM FREQUENCY PER DAY POLICY Oxford MAXIMUM FREQUENCY PER DAY POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE169.49 T0 Effective Date: February 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE...

More information

National Correct Coding Initiative

National Correct Coding Initiative INDIANA HEALTH COVERAGE PROGRAMS PROVIDER REFERENCE M ODULE National Correct Coding Initiative L I B R A R Y R E F E R E N C E N U M B E R : P R O M O D 0 0 0 1 0 P U B L I S H E D : D E C E M B E R 1

More information

Clinical Policy: Brand Name Override Reference Number: CP.PMN.22 Effective Date: Last Review Date: 02.18

Clinical Policy: Brand Name Override Reference Number: CP.PMN.22 Effective Date: Last Review Date: 02.18 Clinical Policy: Reference Number: CP.PMN.22 Effective Date: 09.01.06 Last Review Date: 02.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Modifiers XE, XS, XP, XU, and 59 - Distinct Procedural Service

Modifiers XE, XS, XP, XU, and 59 - Distinct Procedural Service Manual: Policy Title: Reimbursement Policy Modifiers XE, XS, XP, XU, and 59 - Distinct Procedural Service Section: Modifiers Subsection: None Date of Origin: 1/1/2000 Policy Number: RPM027 Last Updated:

More information

Injection and Infusion Services Policy

Injection and Infusion Services Policy REIMBURSEMENT POLICY CMS-1500 Injection and Infusion Services Policy Policy Number 2018R0009A Annual Approval Date 3/8/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS

More information

Modifier 50 - Bilateral Procedure

Modifier 50 - Bilateral Procedure Manual: Policy Title: Reimbursement Policy Modifier 50 - Bilateral Procedure Section: Modifier Subsection: None Date of Origin: 1/1/2000 Policy Number: RPM057 Last Updated: 4/6/2018 Last Reviewed: 4/11/2018

More information

Section: Administrative Subsection: None Date of Origin: 1/22/2004 Policy Number: RPM002 Last Updated: 1/6/2017 Last Reviewed: 1/18/2017

Section: Administrative Subsection: None Date of Origin: 1/22/2004 Policy Number: RPM002 Last Updated: 1/6/2017 Last Reviewed: 1/18/2017 Manual: Policy Title: Reimbursement Policy Clinical Editing Section: Administrative Subsection: None Date of Origin: 1/22/2004 Policy Number: RPM002 Last Updated: 1/6/2017 Last Reviewed: 1/18/2017 IMPORTANT

More information

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy Subject: Claim Editing Overview IN, KY, MO, OH WI Policy: 0027 Effective: 01/01/2018 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products and policy

More information

Clinical Policy: Factor VIIa (Recombinant - NovoSeven RT) Reference Number: CP.PHAR.220

Clinical Policy: Factor VIIa (Recombinant - NovoSeven RT) Reference Number: CP.PHAR.220 Clinical Policy: Factor VIIa (Recombinant - NovoSeven RT) Reference Number: CP.PHAR.220 Effective Date: 05/16 Last Review Date: 05/17 See Important Reminder at the end of this policy for important regulatory

More information

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy Subject: Claim Editing Overview CT Policy: 0027 Effective: 01/01/2018 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products and policy criteria listed

More information

Anthem Blue Cross and Blue Shield Professional Reimbursement Policy

Anthem Blue Cross and Blue Shield Professional Reimbursement Policy Subject: Claim Editing Overview IN, KY, MO, OH WI Policy: 0027 Effective: 05/23/2016 09/30/2016 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products

More information

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Corifact) Reference Number: CP.PHAR.221 Effective Date: 05.01.16 Last Review Date: 02.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end

More information

UniCare Professional Reimbursement Policy

UniCare Professional Reimbursement Policy UniCare Professional Reimbursement Policy Subject: Claim Editing Overview Policy #: UniCare 0027 Adopted: 04/07/2009 Effective: 08/01/2017 Coverage is subject to the terms, conditions, and limitations

More information

Clinical Policy: Irinotecan Liposome (Onivyde) Reference Number: CP.PHAR.304 Effective Date: Last Review Date: 11.18

Clinical Policy: Irinotecan Liposome (Onivyde) Reference Number: CP.PHAR.304 Effective Date: Last Review Date: 11.18 Clinical Policy: (Onivyde) Reference Number: CP.PHAR.304 Effective Date: 02.01.17 Last Review Date: 11.18 Coding Implications Revision Log Line of Business: Medicaid, HIM-Medical Benefit See Important

More information

Clinical Policy: Request for Medically Necessary Drug Not on the PDL Reference Number: CP.PMN.16 Effective Date: Last Review Date: 11.

Clinical Policy: Request for Medically Necessary Drug Not on the PDL Reference Number: CP.PMN.16 Effective Date: Last Review Date: 11. Clinical Policy: Reference Number: CP.PMN.16 Effective Date: 09.01.06 Last Review Date: 11.18 Line of Business: Medicaid See Important Reminder at the end of this policy for important regulatory and legal

More information

Clinical Policy: Sodium phenylbutyrate (Buphenyl) Reference Number: CP.PHAR.208

Clinical Policy: Sodium phenylbutyrate (Buphenyl) Reference Number: CP.PHAR.208 Clinical Policy: (Buphenyl) Reference Number: CP.PHAR.208 Effective Date: 05/16 Last Review Date: 05/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Clinical Policy: Cabozantinib (Cometriq, Cabometyx) Reference Number: CP.PHAR.111

Clinical Policy: Cabozantinib (Cometriq, Cabometyx) Reference Number: CP.PHAR.111 Clinical Policy: (Cometriq, Cabometyx) Reference Number: CP.PHAR.111 Effective Date: 06/13 Last Review Date: 04/17 See Important Reminder at the end of this policy for important regulatory and legal information.

More information

Global Days Policy, Professional

Global Days Policy, Professional REIMBURSEMENT POLICY Global Days Policy, Professional Policy Number 2018R0005D Annual Approval Date 7/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT

More information

MULTIPLE PROCEDURES POLICY

MULTIPLE PROCEDURES POLICY Oxford MULTIPLE PROCEDURES POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: SURGERY 022.34 T0 Effective Date: January 22, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE

More information

Multiple Procedure Payment Reduction (MPPR) for Medical and Surgical Services Policy, Professional

Multiple Procedure Payment Reduction (MPPR) for Medical and Surgical Services Policy, Professional REIMBURSEMENT POLICY CMS-1500 Multiple Payment Reduction (MPPR) for Medical and Surgical Services Policy, Professional Policy Number 2019R0034B Annual Approval Date 7/11/2018 Approved By Reimbursement

More information

UniCare Professional Reimbursement Policy

UniCare Professional Reimbursement Policy UniCare Professional Reimbursement Policy Subject: Modifiers 59 and XE, XP, XS, & XU (Distinct Procedural/Separate/Unusual Service) Policy #: UniCare 0023 Adopted: 08/04/2009 Effective: 07/11/2017 Coverage

More information

Description Irinotecan liposome injection (Onivyde ) is a topoisomerase inhibitor.

Description Irinotecan liposome injection (Onivyde ) is a topoisomerase inhibitor. Clinical Policy: (Onivyde) Reference Number: CP.PHAR.304 Effective Date: 02.01.17 Last Review Date: 11.17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of

More information

Modifier 52 - Reduced Services

Modifier 52 - Reduced Services Manual: Policy Title: Reimbursement Policy Modifier 52 - Reduced Services Section: Modifiers Subsection: None Date of Origin: 9/13/2007 Policy Number: RPM003 Last Updated: 3/6/2017 Last Reviewed: 3/9/2017

More information

J9205 Either ICD-10-CM diagnosis codes C25.4 or C25.9 is required on the claim. Modifiers SA, SB, UD, U7 or 99 are allowed.

J9205 Either ICD-10-CM diagnosis codes C25.4 or C25.9 is required on the claim. Modifiers SA, SB, UD, U7 or 99 are allowed. 4665 Business Center Drive Fairfield, California 94534 Date: 9/27/17 Medi-Cal Important Provider Notice #289 Subject: 2017 HCPC/CPT Code Updates Effective 10/1/17 The 2017 updates to the Current Procedural

More information

Amended Date: October 1, Table of Contents

Amended Date: October 1, Table of Contents Table of Contents 1.0 Description of the Procedure, Product, or Service... 1 1.1 Definitions... 1 1.1.1 Telemedicine... 1 1.1.2 Telepsychiatry... 1 1.1.3 Service Sites... 1 1.1.4 Providers... 1 2.0 Eligibility

More information

Payment Policy Medicine

Payment Policy Medicine Payment Policy Medicine 01/01/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck ND 58506-5585 701-328-3800 800-777-5033 www.workforcesafety.com Copyright Notice The five character codes included in the

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Erwinaze) Reference Number: CP.PHAR.301 Effective Date: 02.01.2017 Last Review Date: 02.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end

More information

Effective date: June 22, 2015 Notification date: March 20, 2015

Effective date: June 22, 2015 Notification date: March 20, 2015 Notification of medical claim payment policy and code-editing updates for professional practitioners Effective date: June 22, 2015 Notification date: March 20, 2015 General reminders: Edits associated

More information

Medically Unlikely Edits (MUE)

Medically Unlikely Edits (MUE) Policy Number MUE10012009RP Medically Unlikely Edits (MUE) Approved By UnitedHealthcare Medicare Committee Current Approval Date 04/13/2016 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is

More information

Clinical Policy: Pralatrexate (Folotyn) Reference Number: CP.PHAR.313 Effective Date: Last Review Date: 11.18

Clinical Policy: Pralatrexate (Folotyn) Reference Number: CP.PHAR.313 Effective Date: Last Review Date: 11.18 Clinical Policy: (Folotyn) Reference Number: CP.PHAR.313 Effective Date: 02.01.17 Last Review Date: 11.18 Coding Implications Revision Log Line of Business: Medicaid, HIM-Medical Benefit See Important

More information

Maximum Frequency Per Day Policy Annual Approval Date

Maximum Frequency Per Day Policy Annual Approval Date Policy Number 2017R0060D Maximum Frequency Per Day Policy Annual Approval Date 7/13/2016 Approved By REIMBURSEMENT POLICY CMS-1500 Payment Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT

More information

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Anti-Inhibitor Coagulant Complex, Human (Feiba) Reference Number: CP.PHAR.217 Effective Date: 05.01.16 Last Review Date: 02.18 Line of Business: Medicaid Coding Implications Revision Log

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Hemlibra) Reference Number: CP.PHAR.370 Effective Date: 01.16.18 Last Review Date: 02.19 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

Clinical Policy: Paricalcitol Injection (Zemplar) Reference Number: CP.PHAR.270

Clinical Policy: Paricalcitol Injection (Zemplar) Reference Number: CP.PHAR.270 Clinical Policy: (Zemplar) Reference Number: CP.PHAR.270 Effective Date: 08.01.16 Last Review Date: 08.18 Line of Business: Medicaid, HIM Medical Benefit Coding Implications Revision Log See Important

More information

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy Subject: Modifiers 59 and XE, XP, XS, XU NY Policy: 0023 Effective: 03/01/2017 03/31/2017 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products and

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Elaprase) Reference Number: CP.PHAR.156 Effective Date: 07.01.18 Last Review Date: 05.18 Line of Business: Oregon Health Plan Coding Implications Revision Log See Important Reminder at

More information

Multiple Procedure Policy

Multiple Procedure Policy Policy Policy Number 2018R0034C Annual Approval Date 7/12/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS You are responsible for submission of accurate claims. This

More information

Payment Policy Medicine

Payment Policy Medicine Payment Policy Medicine 01/01/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck ND 58506-5585 701-328-3800 800-777-5033 www.workforcesafety.com Copyright Notice The five character codes included in the

More information

Reimbursement Policy Subject: Modifier 26 and TC: Professional and Technical Component Coding 07/01/17 08/01/16 https://mediproviders.anthem.

Reimbursement Policy Subject: Modifier 26 and TC: Professional and Technical Component Coding 07/01/17 08/01/16 https://mediproviders.anthem. Anthem Blue Cross Blue Shield Medicaid Reimbursement Policy Subject: Effective Date: 07/01/17 Committee Approval Obtained: 08/01/16 Section: Coding ***** The most current version of our reimbursement policies

More information

Claims and Billing Manual

Claims and Billing Manual 2019 Claims and Billing Manual ProviDRs Care 1/2019 1 Contents Introduction... 3 How to Use This Manual... 3 About WPPA, Inc. dba ProviDRs Care... 3 How to Contact ProviDRs Care... 3 ProviDRs Care Network

More information

Adjunct Professional Services Policy

Adjunct Professional Services Policy Policy Number 2017R7114C Adjunct Professional Services Policy Annual Approval Date 11/9/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS You are responsible for submission

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Lumizyme) Reference Number: CP.PHAR.160 Effective Date: 02.01.16 Last Review Date: 05.18 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

CHAP13-CPTcodes0001T-0999T_final doc Revision Date: 1/1/2017

CHAP13-CPTcodes0001T-0999T_final doc Revision Date: 1/1/2017 CHAP13-CPTcodes0001T-0999T_final103116.doc Revision Date: 1/1/2017 CHAPTER XIII Category III Codes CPT Codes 0001T 0999T FOR NATIONAL CORRECT CODING INITIATIVE POLICY MANUAL FOR MEDICARE SERVICES Current

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Signifor, Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: 03.01.17 Last Review Date: 11.18 Line of Business: Commercial, HIM*, Medicaid Coding Implications Revision Log See

More information

Clinical Policy: Belatacept (Nulojix) Reference Number: CP.PHAR.201 Effective Date: Last Review Date: 11.18

Clinical Policy: Belatacept (Nulojix) Reference Number: CP.PHAR.201 Effective Date: Last Review Date: 11.18 Clinical Policy: (Nulojix) Reference Number: CP.PHAR.201 Effective Date: 03.01.16 Last Review Date: 11.18 Coding Implications Revision Log Line of Business: Medicaid, HIM-Medical Benefit See Important

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services MLN Matters Number: MM8874 Related Change Request (CR) #: CR 8874 Related CR Release Date: April 3, 2015 Effective Date:

More information

Reimbursement Policy Subject: Modifier 26 and TC: Professional and Technical Component Coding 07/01/17 08/01/16 Policy

Reimbursement Policy Subject: Modifier 26 and TC: Professional and Technical Component Coding 07/01/17 08/01/16 Policy Reimbursement Policy Subject: Modifier 26 and TC: Professional and Technical Component Effective Date: Committee Approval Obtained: Section: Coding 07/01/17 08/01/16 *****The most current version of the

More information

Contractor Information. LCD Information. FUTURE Local Coverage Determination (LCD): Frequency of Laboratory Tests (L35099) Document Information

Contractor Information. LCD Information. FUTURE Local Coverage Determination (LCD): Frequency of Laboratory Tests (L35099) Document Information FUTURE Local Coverage Determination (LCD): Frequency of Laboratory Tests (L35099) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Please note: Future

More information

Clinical Policy: Eliglustat (Cerdelga) Reference Number: CP.PHAR.153 Effective Date: 02/16

Clinical Policy: Eliglustat (Cerdelga) Reference Number: CP.PHAR.153 Effective Date: 02/16 Clinical Policy: (Cerdelga) Reference Number: CP.PHAR.153 Effective Date: 02/16 Last Review Date: 02/17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy Subject: Modifier 59 and XE, XP, XS, & XU (Distinct Procedural/Separate/Unusual Service) IN, OH, WI Policy: 0023 Effective: 03/01/2017 04/30/2017 Coverage is subject to the terms, conditions, and limitations

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Synribo) Reference Number: CP.PHAR.108 Effective Date: 04.01.13 Last Review Date: 05.18 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy

Anthem Blue Cross and Blue Shield Commercial Professional Reimbursement Policy Subject: Modifier 59 and XE, XP, XS, & XU (Distinct Procedural/Separate/Unusual Service) IN, KY, MO, OH, WI Policy: 0023 Effective: 01/01/2018 Coverage is subject to the terms, conditions, and limitations

More information

Medically Unlikely Edits Policy

Medically Unlikely Edits Policy Medically Unlikely Edits Policy Policy Number Annual Approval Date 1/13/2017 Approved By Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare

More information

Adjunct Professional Services Policy

Adjunct Professional Services Policy Policy Number 2017R7114K Adjunct Professional Services Policy Annual Approval Date 11/9/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS You are responsible for submission

More information

G0434 DRUG SCREEN, OTHER THAN CHROMATOGRAPHIC; ANY NUMBER OF DRUG CLASSES, BY CLIA WAIVED TEST OR MODERATE COMPLEXITY TEST, PER PATIENT ENCOUNTER

G0434 DRUG SCREEN, OTHER THAN CHROMATOGRAPHIC; ANY NUMBER OF DRUG CLASSES, BY CLIA WAIVED TEST OR MODERATE COMPLEXITY TEST, PER PATIENT ENCOUNTER G0434 DRUG SCREEN, OTHER THAN CHROMATOGRAPHIC; ANY NUMBER OF DRUG CLASSES, BY CLIA WAIVED TEST OR MODERATE COMPLEXITY TEST, PER PATIENT ENCOUNTER Healthcare Common Procedure Coding System The Healthcare

More information

Clinical Policy: Cabazitaxel (Jevtana) Reference Number: CP.PHAR.316 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Cabazitaxel (Jevtana) Reference Number: CP.PHAR.316 Effective Date: Last Review Date: Line of Business: Medicaid Clinical Policy: (Jevtana) Reference Number: CP.PHAR.316 Effective Date: 02.01.17 Last Review Date: 11.17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of

More information

(1) Ambulatory surgical center (ASC) means any center, service, office facility, or other entity that:

(1) Ambulatory surgical center (ASC) means any center, service, office facility, or other entity that: .1 Definitions. Subtitle 09 WORKERS' COMPENSATION COMMISSION 14.09.08 Guide of Medical and Surgical Fees Authority: Labor and Employment Article, 9-309, 9-663 and 9-731, Annotated Code of Maryland Effective

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Mozobil) Reference Number: CP.PHAR.323 Effective Date: 03.01.17 Last Review Date: 08.18 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Elosulfase Alfa (Vimizim) Reference Number: CP.PHAR.162 Effective Date: 02.16 Last Review Date: 05.18 Line of Business: Commercial, Medicaid, HIM-Medical Benefit Coding Implications Revision

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Hemangeol) Reference Number: CP.PMN.58 Effective Date: 05.01.14 Last Review Date: 05.18 Line of Business: HIM, Medicaid Revision Log See Important Reminder at the end of this policy for

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Naglazyme) Reference Number: CP.PHAR.161 Effective Date: 02.16 Last Review Date: 05.18 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy Subject: Modifiers 59 and XE, XP, XS & XU (Distinct Procedural/ Separate/ Unusual Service) NY Policy: 0023 Effective: 08/22/2016 11/20/2016 Coverage is subject to the terms, conditions, and limitations

More information

Medically Unlikely Edits (MUE)

Medically Unlikely Edits (MUE) Policy Number MUE10012009RP Medically Unlikely Edits (MUE) Approved By UnitedHealthcare Medicare Committee Current Approval Date 09/11/2013 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is

More information

Clinical Policy: Temsirolimus (Torisel) Reference Number: CP.PHAR.324 Effective Date: Last Review Date: Line of Business: HIM, Medicaid

Clinical Policy: Temsirolimus (Torisel) Reference Number: CP.PHAR.324 Effective Date: Last Review Date: Line of Business: HIM, Medicaid Clinical Policy: (Torisel) Reference Number: CP.PHAR.324 Effective Date: 03.01.17 Last Review Date: 11.18 Line of Business: HIM, Medicaid Coding Implications Revision Log See Important Reminder at the

More information

Co-Surgeon / Team Surgeon Policy

Co-Surgeon / Team Surgeon Policy Co-Surgeon / Team Surgeon Policy Policy Number 2018R0052C Annual Approval Date 7/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY You are responsible

More information

29:10 NORTH CAROLINA REGISTER NOVEMBER 17,

29:10 NORTH CAROLINA REGISTER NOVEMBER 17, Note from the Codifier: The notices published in this Section of the NC Register include the text of proposed rules. The agency must accept comments on the proposed rule(s) for at least 60 days from the

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Iclusig) Reference Number: CP.PHAR.112 Effective Date: 06.01.13 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services NEW product from the Medicare Learning Network (MLN) Affordable Care Act Provider Compliance Programs: Getting Started Web-Based

More information

Clinical Policy: Ruxolitinib (Jakafi)

Clinical Policy: Ruxolitinib (Jakafi) Clinical Policy: (Jakafi) Reference Number: CP.PHAR.98 Effective Date: 03/12 Last Review Date: 04/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

UniCare ClaimsXten TM Rules (Version 4.4) Effective February 15, 2013

UniCare ClaimsXten TM Rules (Version 4.4) Effective February 15, 2013 UniCare ClaimsXten TM Rules (Version 4.4) Effective February 15, 2013 Rules Edit logic Example Supported After Hours 99050 not Reimbursable with Preventive Diagnosis Qualitative Drug Screening This will

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Burosumab-twza (Crysvita) Reference Number: CP.PHAR.11 Effective Date: 10.01.18 Last Review Date: 07.13.18 Line of Business: Oregon Health Plan Coding Implications Revision Log See Important

More information

UNUSUAL NON-OVERLAPPING SERVICE, THE USE OF A SERVICE THAT IS DISTINCT BECAUSE IT DOES NOT OVERLAP USUAL COMPONENTS OF THE MAIN SERVICE

UNUSUAL NON-OVERLAPPING SERVICE, THE USE OF A SERVICE THAT IS DISTINCT BECAUSE IT DOES NOT OVERLAP USUAL COMPONENTS OF THE MAIN SERVICE XU UNUSUAL NON-OVERLAPPING SERVICE, THE USE OF A SERVICE THAT IS DISTINCT BECAUSE IT DOES NOT OVERLAP USUAL COMPONENTS OF THE MAIN SERVICE Healthcare Common Procedure Coding System The Healthcare Common

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Firazyr) Reference Number: CP.PHAR.178 Effective Date: 07.01.18 Last Review Date: 02.18 Line of Business: Oregon Health Plan Coding Implications Revision Log See Important Reminder at

More information

CONNECTIONS CONVERSION TO ICD-10-CM DIAGNOSIS CODING SYSTEM HOLIDAY SCHEDULE

CONNECTIONS CONVERSION TO ICD-10-CM DIAGNOSIS CODING SYSTEM HOLIDAY SCHEDULE CONVERSION TO ICD-10-CM DIAGNOSIS CODING SYSTEM Providence Health Plan (PHP) will be adopting ICD-10- CM codes (diagnosis codes) effective October 1, 2014, in conjunction with Centers for Medicare and

More information

Age to Diagnosis Code & Procedure Code Policy

Age to Diagnosis Code & Procedure Code Policy Age to Diagnosis Code & Procedure Code Policy Policy Number 2017R0086C Annual Approval Date 3/8/2017 Approved By Reimbursement Policy Oversight Committee You are responsible for submission of accurate

More information